Literature DB >> 8468487

Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells.

M Tardif1, L Mery, L Brouchon, F Boulay.   

Abstract

Attenuation of signaling is a key step in controlling the cytotoxic potential of leukocyte responses to chemotactic factors. Antipeptide antibodies, directed against the N-formyl chemotactic peptide receptor (FPR) and the activation peptide from the fifth component of C (C5a) anaphylatoxin receptor (C5aR) of human neutrophils, were used to analyze the ability of these receptors to be phosphorylated. Our data show that, in granulocyte-like differentiated HL-60 cells, both FPR and C5aR undergo an agonist dose-dependent phosphorylation that reaches completion in less than 2 to 3 min, consistent with the rate and the dose-dependent attenuation of signaling in phagocytes. Therefore, phosphorylation might be one of the possible mechanisms involved in the desensitization process of FPR and C5aR. Addition of either C5a or the protein kinase C activator (PMA) did not appear to induce the phosphorylation of FPR in the absence of FMLP or to modulate the phosphorylation of the latter at low concentrations of agonist. In contrast, although FMLP at a saturating concentration barely stimulated the phosphorylation of unoccupied C5aR, it markedly potentiated C5aR phosphorylation in cells exposed to low concentrations of C5a. Moreover, PMA was able to induce C5aR phosphorylation in the absence of agonist, indicating that protein kinase C or protein kinase C-activated kinase(s) could be involved in the phosphorylation of C5aR. Pretreatment of cells with staurosporine, a potent but nonspecific inhibitor of protein kinase C, resulted in the partial inhibition of both FPR and C5aR phosphorylation induced by saturating concentrations of agonist, suggesting that a kinase different from protein kinase C might be mainly responsible for the phosphorylation of these chemotactic receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8468487

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Redox signaling mediated by the gut microbiota.

Authors:  Andrew S Neish
Journal:  Free Radic Res       Date:  2013-10-04

2.  Chemerin C9 peptide induces receptor internalization through a clathrin-independent pathway.

Authors:  Jun-xian Zhou; Dan Liao; Shuo Zhang; Ni Cheng; Hui-qiong He; Richard D Ye
Journal:  Acta Pharmacol Sin       Date:  2014-03-24       Impact factor: 6.150

Review 3.  Expression and signaling of formyl-peptide receptors in the brain.

Authors:  Fabio Cattaneo; Germano Guerra; Rosario Ammendola
Journal:  Neurochem Res       Date:  2010-11-02       Impact factor: 3.996

Review 4.  Reactive oxygen production induced by the gut microbiota: pharmacotherapeutic implications.

Authors:  R M Jones; J W Mercante; A S Neish
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 5.  Molecular biology for formyl peptide receptors in human diseases.

Authors:  Yongsheng Li; Duyun Ye
Journal:  J Mol Med (Berl)       Date:  2013-02-13       Impact factor: 4.599

6.  Multistep navigation and the combinatorial control of leukocyte chemotaxis.

Authors:  E F Foxman; J J Campbell; E C Butcher
Journal:  J Cell Biol       Date:  1997-12-01       Impact factor: 10.539

7.  N-formyl peptide receptor 3 (FPR3) departs from the homologous FPR2/ALX receptor with regard to the major processes governing chemoattractant receptor regulation, expression at the cell surface, and phosphorylation.

Authors:  Marie-Josèphe Rabiet; Laurence Macari; Claes Dahlgren; François Boulay
Journal:  J Biol Chem       Date:  2011-05-04       Impact factor: 5.157

Review 8.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

9.  Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.

Authors:  M Oppermann; O Götze
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

10.  Complement component 5a receptor oligomerization and homologous receptor down-regulation.

Authors:  Marie-Josèphe Rabiet; Emilie Huet; François Boulay
Journal:  J Biol Chem       Date:  2008-09-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.